Open access · OA
via OpenAlex
Inflammatory biomarkers in Alzheimer's disease plasma
Angharad R. Morgan, Samuel Touchard, Claire A. Leckey, Caroline O’Hagan, Alejo Nevado‐Holgado, Frederik Barkhof, Lars Bertram, Olivier Blin, Isabelle Bos, Valerija Dobričić, Sebastiaan Engelborghs, Giovanni B. Frisoni, Lutz Frölich, Silvey Gabel, Peter Johannsen
Alzheimer s & Dementia · 2019 · ▲ 209 citations
Abstract
INTRODUCTION: Plasma biomarkers for Alzheimer's disease (AD) diagnosis/stratification are a "Holy Grail" of AD research and intensively sought; however, there are no well-established plasma markers. METHODS: A hypothesis-led plasma biomarker search was conducted in the context of international multicenter studies. The discovery phase measured 53 inflammatory proteins in elderly control (CTL; 259), mild cognitive impairment (MCI; 199), and AD (262) subjects from AddNeuroMed. RESULTS: Ten analytes showed significant intergroup differences. Logistic regression identified five (FB, FH, sCR1, MCP-1, eotaxin-1) that, age/APOε4 adjusted, optimally differentiated AD and CTL (AUC: 0.79), and three (sCR1, MCP-1, eotaxin-1) that optimally differentiated AD and MCI (AUC: 0.74). These models replicated in an independent cohort (EMIF; AUC 0.81 and 0.67). Two analytes (FB, FH) plus age predicted MCI progression to AD (AUC: 0.71). DISCUSSION: Plasma markers of inflammation and complement dysregulation support diagnosis and outcome prediction in AD and MCI. Further replication is needed before clinical translation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.jalz.2019.03.007
- Canonical
- link ↗
- Fetched
- 2026-07-28 MST
Cite this
APA
Morgan, A.R., Touchard, S., Leckey, C.A., O’Hagan, C., Nevado‐Holgado, A., Barkhof, F., Bertram, L., Blin, O., Bos, I., Dobričić, V., Engelborghs, S., Frisoni, G.B., Frölich, L., Gabel, S., Johannsen, P., Kettunen, P., Kłoszewska, I., Legido‐Quigley, C., Lleó, A., & Martínez‐Lage, P. (2019). Inflammatory biomarkers in Alzheimer's disease plasma. <em>Alzheimer s & Dementia</em>. https://doi.org/10.1016/j.jalz.2019.03.007
Vancouver
Morgan AR, Touchard S, Leckey CA, O’Hagan C, Nevado‐Holgado A, Barkhof F, et al. Inflammatory biomarkers in Alzheimer's disease plasma. Alzheimer s & Dementia. 2019. doi:10.1016/j.jalz.2019.03.007.
BibTeX
@article{angharad2019Inflam,
title = {Inflammatory biomarkers in Alzheimer's disease plasma},
author = {Angharad R. Morgan and Samuel Touchard and Claire A. Leckey and Caroline O’Hagan and Alejo Nevado‐Holgado and Frederik Barkhof and Lars Bertram and Olivier Blin and Isabelle Bos and Valerija Dobričić and Sebastiaan Engelborghs and Giovanni B. Frisoni and Lutz Frölich and Silvey Gabel and Peter Johannsen and Petronella Kettunen and Iwona Kłoszewska and Cristina Legido‐Quigley and Alberto Lleó and Pablo Martínez‐Lage and Patrizia Mecocci and Karen Meersmans and José Luís Molinuevo and Gwendoline Peyratout and Julius Popp},
journal = {Alzheimer s & Dementia},
year = {2019},
doi = {10.1016/j.jalz.2019.03.007},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Alzheimer s & Dementia 2026
Open access · CC-BY
Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration
Ear and Hearing 2018
Preprint · OA
Biomarkers of Systemic Inflammation and Risk of Incident Hearing Loss
Kidney International Reports 2026
Open access · CC-BY
The Associations of Heart Rate Variability With Inflammatory Biomarkers
Amoneta Diagnostics SAS 2019
Open access · US-GOV
Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's Disease
Clinical Epigenetics 2018
Open access · OA
MEST mediates the impact of prenatal bisphenol A exposure on long-term body weight development
The journal of nutrition health & aging 2019
Open access · CC-BY